文献速递急性肾损伤遗传性与小管间质肾病

基于电子健康记录的急性肾小管间质性肾炎诊断模型的外部验证

External Validation of an Electronic Health Record-Based Diagnostic Model for Histological Acute Tubulointerstitial Nephritis.
PubMed 文献 · J Am Soc Nephrol · 2024-11-05

该研究在约翰霍普金斯医院和耶鲁大学两个活检队列中验证了先前开发的基于四项实验室检查的急性肾小管间质性肾炎(AIN)诊断模型。模型在两个验证队列中保持区分度(AUC均为0.73),但校准不完美,经截距校正后改善。模型将临床医生活检前怀疑AIN的AUC提高了0.10至0.77。

要点

  • 四联实验室检查模型在外部队列中维持AUC 0.73,与开发队列相似。
  • 验证队列AIN患病率低于开发队列,需截距校正改善校准。
  • 模型在临床医生活检前怀疑基础上将AUC提高0.10至0.77。

核心结论

  • AIN诊断模型在两个外部验证队列中保持区分度,但需根据当地AIN患病率重新校准。
  • 模型提高了临床医生预测活检确诊AIN的能力。

研究设计与样本

  • 研究分析了2019至2023年在约翰霍普金斯医院和耶鲁大学接受肾活检的患者。
  • 共纳入1982例参与者,其中约翰霍普金斯医院1454例,耶鲁大学528例。
  • 使用先前推导的模型系数评估区分度(AUC)和校准,并采用截距校正因子重新校准。

主要发现

  • 约翰霍普金斯医院活检中AIN比例为5%,耶鲁大学为17%,均低于开发集的23%。
  • 约翰霍普金斯医院AUC为0.73(95%CI 0.66-0.79),耶鲁大学AUC为0.73(95%CI 0.67-0.78),与开发集0.73(95%CI 0.64-0.81)相似。
  • 验证队列校准不完美,尤其在约翰霍普金斯医院,但应用截距校正因子后改善。
  • 模型将临床医生活检前怀疑AIN的AUC提高了0.10至0.77(95%CI 0.71-0.82)。

临床怎么用

  • 该模型可辅助临床医生在肾活检前预测AIN,但应用时需根据当地AIN患病率进行校准。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

KEY POINTS: Individual noninvasive diagnostic tests lack accuracy for diagnosing histological acute tubulointerstitial nephritis. A validated diagnostic model combining four clinical tests accurately predicted acute tubulointerstitial nephritis on biopsy in two separate populations. BACKGROUND: Accurate diagnosis of acute tubulointerstitial nephritis (AIN) often requires a kidney biopsy. We previously developed a diagnostic statistical model for predicting biopsy-confirmed AIN by combining four laboratory tests after evaluating over 150 potential predictors from the electronic health record. In this study, we validate this diagnostic model in two biopsy-based cohorts at Johns Hopkins Hospital (JHH) and Yale University, which were geographically and temporally distinct from the development cohort, respectively. METHODS: We analyzed patients who underwent kidney biopsy at JHH and Yale University (2019–2023). We assessed discrimination (area under receiver-operating characteristics curve [AUC]) and calibration using previously derived model coefficients and recalibrated the model using an intercept correction factor that accounted for differences in baseline prevalence of AIN between development and validation cohorts. RESULTS: We included 1982 participants: 1454 at JHH and 528 at Yale. JHH (5%) and Yale (17%) had lower proportions of biopsies with AIN than the development set (23%). The AUC was 0.73 (95% confidence interval [CI], 0.66 to 0.79) at JHH and 0.73 (95% CI, 0.67 to 0.78) at Yale, similar to the development set (0.73 [95% CI, 0.64 to 0.81]). Calibration was imperfect in validation cohorts, particularly at JHH, but improved with the application of an intercept correction factor. The model increased AUC of clinicians’ prebiopsy suspicion for AIN by 0.10 to 0.77 (95% CI, 0.71 to 0.82). CONCLUSIONS: An AIN diagnostic model retained discrimination in two validation cohorts but needed recalibration to account for local AIN prevalence. The model improved clinicians’ ability to predict AIN.

来源:J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Moledina DG, Shelton K, Menez S, et al. External Validation of an Electronic Health Record-Based Diagnostic Model for Histological Acute Tubulointerstitial Nephritis. J Am Soc Nephrol. 2024. PMID: 39500309. doi:10.1681/ASN.0000000556

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。